Seth Klarman’s portfolio: Baupost Group 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001061768Latest: Q2 2026

Q4 2013 filing in brief

In its Q4 2013 13F, filed February 13, 2014, Baupost Group reported $3.5B across 19 US positions. The largest: MU (31.8%), THERAVANCE INC (20.4%), VSAT (19.8%), BP (7.8%), IDENIX PHARMACEUTICALS INC (6.3%). In the quarter it opened 3 positions, sold out of 4, added to 6 and trimmed 3; positions opened and sold out came to 6.3% of the portfolio's value.

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed Feb 13, 2014

  • 3 New
  • 6 Added
  • 3 Trimmed
  • 4 Exited

19 positions at December 31, 2013. Q/Q change compares shares with the preceding quarter.

RowTickerIssuerStatus
1MUMICRON TECHNOLOGY INC$1.1B51.7M31.83%−19.3%Trimmed
2—THERAVANCE INC$718M20.1M20.35%+8.8%Added
3VSATVIASAT INC$697M11.1M19.76%+1.2%Added
4BPBP PLC$275M5.7M7.80%+1.2%Added
5—IDENIX PHARMACEUTICALS INC$221M36.9M6.25%+24.4%Added
6—CITIGROUP INC$68M104.2M1.92%+10.6%Added
7—FIDELITY NATIONAL FINANCIAL$64M2.0M1.82%—New
8—CHIPMOS TECH BERMUDA LTD$63M3.3M1.79%0.0%Held
9PBFPBF ENERGY INC$62M2.0M1.76%+106.9%Added
10NGNOVAGOLD RES INC$55M21.7M1.56%0.0%Held
11—SYNERON MEDICAL LTD$49M4.0M1.39%0.0%Held
12ROVIEURROVI CORP$43M2.2M1.21%−64.9%Trimmed
13KIN1USDKINDRED BIOSCIENCES INC$32M2.9M0.92%—New
14—ALLIANCE ONE INTL INC$19M6.4M0.55%0.0%Held
15—AMERICAN INTL GROUP INC$13M656.4K0.38%0.0%Held
16—NOVACOPPER INC$8M5.0M0.22%0.0%Held
17AVEOEURAVEO PHARMACEUTICALS INC$7M3.8M0.20%0.0%Held
18ALDWUSDALON USA PARTNERS LP$5M329.2K0.16%—New
19ENZNEURENZON PHARMACEUTICALS INC$5M4.3M0.14%−43.6%Trimmed
4 exited positions

Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.

TickerIssuerPrevious valuePrevious shares
ORCLORACLE CORP$79M2.4M
MU 1.875 06/01/27MICRON TECHNOLOGY INC$18M11.4M
CPFCENTRAL PAC FINL CORP$14M779.7K
—ITURAN LOCATION AND CONTROL$9M476.3K
Every quarter on file (53)

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.